Decentralised molecular testing for TB could reduce missed diagnoses and losses to follow-up in high-burden settings.
A study published in The Lancet Global Health reported on the cost and cost-effectiveness analysis of decentralised molecular testing for TB in Uganda.
An accompanying comment can be accessed here.